ACM
BLUE

ADAR1 Capital Management’s bluebird bio BLUE Stock Holding History

ADAR1 Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-300
Closed -$5.91K – 291
2024
Q2 		$5.91K Buy
300
+50
+20% +$1K ﹤0.01% 239
2024
Q1 		$6.4K Buy
+250
New +$6.41K ﹤0.01% 236

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ADAR1 Capital Management's BLUE Position: Q3 2024 in Review

ADAR1 Capital Management sold out of bluebird bio (BLUE) in Q3 2024, closing a stake of 300 shares — an estimated $5.91K sold.

ADAR1 Capital Management first reported a position in BLUE in Q1 2024 and held it in 2 quarters. The position peaked at $6.4K in Q1 2024. 140 funds tracked by Wall St. Rank hold BLUE as of Q3 2024.

  • ADAR1 Capital Management reported no remaining bluebird bio position as of Q3 2024 after selling out during the quarter.
  • ADAR1 Capital Management sold 300 bluebird bio shares in Q3 2024, an estimated $5.91K.
  • ADAR1 Capital Management first reported a position in bluebird bio in Q1 2024 and held it in 2 quarters.
  • ADAR1 Capital Management's bluebird bio position peaked at $6.4K in Q1 2024.
  • 140 funds tracked by Wall St. Rank held bluebird bio as of Q3 2024.

Based on ADAR1 Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.